Thanks, @13th for adding a little more colour to my article...

Thanks, @13th for adding a little more colour to my article dump. I am sure there are a number of deals on foot at the moment.

Three weeks today/tomorrow until the quarterly is due, aren't these three-month blocks flying by! Newsflow was ramped in the lead to the call at end of April, I expect the same for this quarterly.


I suspect the market is monitoring closely, yet on the sidelines waiting for;
- FDA submission and whether or not the approval process will be fast-tracked
- The launch of consumer product (I note this was pushed back again in last investor deck on 12/6) to Q2 FY19
- Uptake numbers on the corporate product and specifically the subscription-based product

Frustrating nonetheless.

Mr.G